These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection. Patel JR, Didlick S, Bateman H. Equine Vet J; 2004 Jul; 36(5):447-51. PubMed ID: 15253088 [Abstract] [Full Text] [Related]
26. The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens. Breathnach CC, Yeargan MR, Sheoran AS, Allen GP. Equine Vet J; 2001 Nov; 33(7):651-7. PubMed ID: 11770985 [Abstract] [Full Text] [Related]
27. Vaccination of mares against equine herpesvirus-1. Pickles AC. Vet Rec; 1992 Feb 22; 130(8):167-8. PubMed ID: 1314446 [No Abstract] [Full Text] [Related]
28. Clinical, serological and molecular investigations of EHV-1 and EHV-4 in 15 unweaned thoroughbred foals. Marenzoni ML, Passamonti F, Cappelli K, Veronesi F, Capomaccio S, Supplizi AV, Valente C, Autorino G, Coletti M. Vet Rec; 2008 Mar 15; 162(11):337-41. PubMed ID: 18344498 [Abstract] [Full Text] [Related]
29. Vaccines for EHV1 abortion. Mitchell D. Vet Rec; 1983 Mar 19; 112(12):285. PubMed ID: 6302971 [No Abstract] [Full Text] [Related]
30. Seroprevalence of equine herpesvirus 1 in mares and foals on a large Hunter Valley stud farm in years pre- and postvaccination. Foote CE, Gilkerson JR, Whalley JM, Love DN. Aust Vet J; 2003 May 19; 81(5):283-8. PubMed ID: 15084039 [Abstract] [Full Text] [Related]
35. Development and validation of a monoclonal antibody blocking ELISA for the detection of antibodies against both equine herpesvirus type 1 (EHV1) and equine herpesvirus type 4 (EHV4). van Maanen C, de Boer-Luijtze E, Terpstra C. Vet Microbiol; 2000 Jan 19; 71(1-2):37-51. PubMed ID: 10665532 [Abstract] [Full Text] [Related]
37. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine. Wagner B, Goodman LB, Babasyan S, Freer H, Torsteinsdóttir S, Svansson V, Björnsdóttir S, Perkins GA. Vaccine; 2015 Oct 13; 33(42):5588-5597. PubMed ID: 26384446 [Abstract] [Full Text] [Related]
38. Immunity and the level of neutralization antibodies in foals and mares vaccinated with a modified live-virus rhinopneumonitis vaccine. Dutta SK, Shipley WD. Am J Vet Res; 1975 Apr 13; 36(4 Pt.1):445-8. PubMed ID: 164808 [Abstract] [Full Text] [Related]
39. Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture. Eaglesome MD, Henry JN, McKnight JD. Can Vet J; 1979 May 13; 20(5):145-7. PubMed ID: 226261 [Abstract] [Full Text] [Related]
40. Equine herpesvirus type 1 mutant defective in glycoprotein E gene as candidate vaccine strain. TSUJIMURA K, SHIOSE T, YAMANAKA T, NEMOTO M, KONDO T, MATSUMURA T. J Vet Med Sci; 2009 Nov 13; 71(11):1439-48. PubMed ID: 19959893 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]